Steven Cohen Inotiv, Inc. Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$3.01 - $7.32 $168 - $409	-56 Reduced 1.44%	3,824 $11,000
Q2 2023 Aug 14, 2023	SELL	$4.08 - $7.22 $18,355 - $32,482	-4,499 Reduced 53.69%	3,880 $18,000
Q1 2023 May 15, 2023	BUY	$4.18 - $8.64 $35,024 - $72,394	8,379 New	8,379 $36,000
Q3 2022 Nov 14, 2022	BUY	$9.81 - $26.17 $3.39 Million - $9.04 Million	345,376 Added 198.99%	518,937 $8.74 Million
Q2 2022 Aug 15, 2022	BUY	$9.56 - $25.91 $1.66 Million - $4.5 Million	173,561 New	173,561 $1.67 Million

3.67M

1.1K

21.3K

Ticker NOTV
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 25,594,500
Market Cap $104M
Description
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.